Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Tutorials: Molecular Characterization of CTCs
  Microfluidic System Designed to Deliver Optimized Sample for Downstream Analysis
• Feature Articles: Microfluidics Advances in New Directions
  
• Feature Articles: Boosting Gene Expression Profiling
  
• Feature Articles: Visualizing Cell Signaling Pathways
  
• Tech Notes: Pathogen and Cancer Biomarker Genotyping
  Gene-Analysis Studies Advanced by Use of Low-Volume High-Throughput Real-Time PCR

• Insight & Intelligence™

• More »

• A Cyber War on Cancer
  September 20, 2012
  New strategies are hoping to put an end to the war that Richard Nixon declared four decades ago.

• GEN News Highlights

• More »

• Wandering Tumor Cells May Seed Metastasis in Breast Cancer
  
• Lung Cancer Blood Test Could Be Epic Development
  
• NCI Grants MabVax $150K for Neuroblastoma Vaccine
  
• Childhood Cancer-Linked Mutations May Point Toward New Targets
  
• Blood Biomarker Identifies Early Lung Cancer
  

• New Products

• More »

Swift Biosciences BRAF Mutation Detection myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single-copy detection of BRAF mutations. myT BRAF-Ultra can detect less than 10 copies of mutant BRAF V600E/K with low breakthrough amplification from a backg